Marijuana
17
1
3
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
31%
4 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (17)
Neuroimaging of Adolescent Cannabis Use Treatment
Marijuana's Impact on Alcohol Motivation and Consumption
Do Discounted Vouchers for Medical Cannabis Reduce Opioid Use in Adults With Pain
Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study
Tetrahydrocannabinol (THC) and Sleep
Warrior CARE: Cannabis Behavioral Health
Contingency Management for Cannabis Use for Persons With HIV
Probing the Cannabinoid System in Individuals With a Family History of Psychosis
THC Memory & Reward Learning Pilot
Marijuana Effects on Simulated Driving Performance
Does Medical Cannabis Reduce Opioid Use in Adults With Pain
MEMO-Medical Marijuana and Opioids Study
Analgesic Consumption in Chronic Marijuana Users Following Orthopedic Trauma Surgery
Families With Substance Use and Psychosis: A Pilot Study
Do Adolescents and Adults Differ in Their Acute Response to Cannabis?
Helping Eliminate Marijuana Use Through Pediatric Practice
Brief Interventions With Text Messaging to Reduce Adolescent Alcohol and Marijuana Use